- Home
- MBI vs KALV Comparison
MBI vs KALV Comparison
Compare MBI & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- KALV
- Stock Information
- Founded
- MBI 1973
- KALV N/A
- Country
- MBI United States
- KALV United States
- Employees
- MBI N/A
- KALV N/A
- Industry
- MBI Property-Casualty Insurers
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- KALV Health Care
- Exchange
- MBI Nasdaq
- KALV Nasdaq
- Market Cap
- MBI 311.3M
- KALV 362.2M
- IPO Year
- MBI 1987
- KALV N/A
- Fundamental
- Price
- MBI $6.81
- KALV $10.03
- Analyst Decision
- MBI Buy
- KALV Strong Buy
- Analyst Count
- MBI 2
- KALV 8
- Target Price
- MBI $6.75
- KALV $25.67
- AVG Volume (30 Days)
- MBI 398.4K
- KALV 334.3K
- Earning Date
- MBI 03-07-2025
- KALV 03-10-2025
- Dividend Yield
- MBI N/A
- KALV N/A
- EPS Growth
- MBI N/A
- KALV N/A
- EPS
- MBI N/A
- KALV N/A
- Revenue
- MBI N/A
- KALV N/A
- Revenue This Year
- MBI N/A
- KALV N/A
- Revenue Next Year
- MBI N/A
- KALV N/A
- P/E Ratio
- MBI N/A
- KALV N/A
- Revenue Growth
- MBI N/A
- KALV N/A
- 52 Week Low
- MBI $3.22
- KALV $7.30
- 52 Week High
- MBI $7.46
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- MBI 50.66
- KALV 59.09
- Support Level
- MBI $7.04
- KALV $8.99
- Resistance Level
- MBI $7.28
- KALV $11.00
- Average True Range (ATR)
- MBI 0.34
- KALV 0.57
- MACD
- MBI -0.02
- KALV 0.11
- Stochastic Oscillator
- MBI 14.94
- KALV 57.08
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.